Clinical trials
Completed Phase 2 Hyperlipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Toronto | 5 |
| Amgen | 4 |
| Akcea Therapeutics | 3 |
| AstraZeneca | 3 |
| Kastle Therapeutics, LLC | 3 |
| Aegerion Pharmaceuticals, Inc. | 2 |
| Esperion Therapeutics, Inc. | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Takeda | 2 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 59 |
| Dyslipidemias | 17 |
| Hypercholesterolemia | 16 |
| Cardiovascular Diseases | 13 |
| Lipid Metabolism Disorders | 9 |
| Metabolic Diseases | 8 |
| Hypertension | 6 |
| Diabetes Mellitus | 5 |
| Insulin Resistance | 5 |
| Heart Diseases | 4 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.